The strongest mechanistic support for cerebral organotropism was identified in breast cancer, oncogene-driven non-small cell lung cancer, and melanoma, while the biological pathways underlying brain metastasis in renal cell carcinoma and colorectal cancer remain comparatively less defined.
Abstract
BACKGROUND
Brain metastasis is a major contributor to morbidity in advanced cancer, with substantial variability in incidence and biological behavior across primary tumor types and molecular subtypes. Increasing evidence suggests that cerebral organotropism is driven by coordinated interactions between tumor-intrinsic programs and the specialized brain microenvironment. This review aimed to synthesize contemporary mechanistic evidence underlying brain-tropic metastasis and identify biologically actionable bottlenecks involved in metastatic progression within the central nervous system.
SUMMARY
We conducted a mechanism-focused narrative review of recent neuro-oncology literature examining the biological processes that facilitate brain-specific metastatic dissemination. Four major mechanistic domains were evaluated: (1) extracellular vesicle and exosome-mediated conditioning of the brain vascular-immune niche; (2) cerebral microvascular arrest and endothelial adhesion under shear stress facilitating tumor transmigration; (3) brain-tumor barrier remodeling and endothelial-state heterogeneity influencing permeability and transport; and (4) perivascular metastatic progression shaped by astrocytic and microglial/myeloid microenvironments. The strongest mechanistic support for cerebral organotropism was identified in breast cancer, oncogene-driven non-small cell lung cancer, and melanoma. In contrast, the biological pathways underlying brain metastasis in renal cell carcinoma and colorectal cancer remain comparatively less defined.
KEY MESSAGES
Cerebral organotropism appears to emerge through iterative tumor subclone evolution coupled with dynamic host microenvironmental reprogramming. Coordinated vascular, immune, and glial interactions represent critical mechanistic checkpoints governing metastatic seeding and survival in the brain. Future advances in prediction and prevention will require subtype-resolved and spatially informed human validation studies, alongside mechanistically grounded therapeutic strategies targeting vascular docking, barrier remodeling, and glial-myeloid support pathways.
Lung cancer brain metastasis (LCBM) is a major cause of cancer-related mortality, driven by the restrictive blood–brain barrier (BBB), an immunosuppressive microenvironment, and dynamic metabolic reprogramming. Increasing evidence suggests that LCBM is governed by coordinated interactions among neural, immune, and vasc...
Jiaojiao Li, Mingjun Xu, Lei Wang et al.· Frontiers in Immunology· 0 citations
Brain metastasis is a major contributor to poor prognosis in cancer patients, with therapeutic efficacy severely constrained by the blood-brain barrier and the complex brain microenvironment. Although lipid metabolic reprogramming has been linked to tumor progression across multiple cancer types, its mechanistic involv...
Xue-Fang Huang, Xin-Miao Xian, Hong-Yuan Zhang et al.· Biochimica et biophysica act...· 0 citations
ABSTRACT Lung cancer brain metastasis (LCBM) remains one of the most challenging clinical conditions limiting survival and neurological function. The development of LCBM is shaped by continuous exchange of molecular signals between tumor cells and the brain microenvironment, involving blood–brain barrier remodeling, gl...
Jun Yang, Jun-Yi Xiong, Li Ying et al.· Cancer Science· 0 citations
Glioblastoma (GBM) combines heterogeneous vascular dysfunction with a predominantly myeloid immune landscape. This Mini Review focuses on a specific problem: vascular permeability is not equivalent to productive leukocyte access. Entry requires endothelial capture, chemokine-guided arrest, transendothelial migration, r...
Fang-Bo Lin· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.